Toward the Modulation of Physiological Salivary Secretion
Development of Next-Generation Therapeutics for Xerostomia
We develop drugs that modulate the body’s intrinsic salivary secretion mechanisms to support natural and sustained functional improvement.
Who We Are
Fumihiro Nakamori Ph.D. MBA
Board Member (outside)
・TOHOKU University Venture Partners
Vice President, Investment Department
Audit & Supervisory Board Member (outside)
・Former Megabank
General Manager of Corporate Business Office
・Former Regional Bank
Director and Senior Managing
Executive Officer
Kozo Isshiki
We are an R&D-driven biotechnology company founded by experts in drug discovery and business development. Guided by a philosophy that respects the body’s inherent functions, we focus on small-molecule drug discovery to create new therapeutic options for xerostomia.
We are committed to addressing unmet medical needs by providing patients with new, scientifically grounded therapeutic options.
Our Mission
To advance meaningful patient benefit and the evolution of healthcare, while creating sustainable social and business value.
Our Vision
Company profile
About Us
Company Name: Asahi Pharma Co., Ltd.
Representative: Keni Nii (President & CEO)
Address: 2-5-1 Azama, Tsukuba, Ibaraki 305-0031, Japan
Founded: February 2022
Business Activities: Research and development of novel small-molecule therapeutics
Focus Area: Xerostomia (dry mouth)
Our team
Our team is composed of professionals with extensive hands-on experience in drug discovery and business development.
Keni Nii Ph.D.
President & CEO
・Founder
・Former Head of the Neuroscience Research Laboratory, Astellas Pharma Inc.
Taiji Sawamoto Ph.D.
Chief Operating Officer
・Overall Executive Lead
・Former Visiting Professor, Nagoya University Graduate School of Medicine
・Former Corporate Executive and General Manager, Tsukuba Research Center, Astellas Pharma Inc.
Masanori Sato
Executive Officer (Business Development)
・Representative, ReachMed
Partners LLC
・Held senior leadership roles in Business Development across major Japanese and multinational pharmaceutical companies
Michihisa Higashida Ph.D.
General Affairs Manager
・General Affairs
・Former University of Toyama Associate Professor
(Basic Research: Director of Consilienceology for Wakan-
yaku)
